Bio Jobs | 08 May 2024 | News
Turbulence in Pharma: A Wave of Layoffs Sweeps Through the Industry
The pharmaceutical and biotechnology industries are undergoing a significant upheaval, with a series of layoff...Read more
Clinical Trials | 01 May 2024 | Opinion
What Are the Main Challenges of Modern Clinical Trials?
While the increasing volume of clinical data is welcome in many respects, clinicians and trial managers often ...Read more
Clinical Trials | 01 May 2024 | Opinion
“Regulatory encouragement of advanced tech, including AI will accelerate clinical trials in APAC”
Could you elaborate on the most prominent trends shaping the APAC clinical trials landscape? One of Lokavant&...Read more
BioTech | 01 May 2024 | Opinion
From Hematologic to Autoimmune Disease – The CAR-T Therapy Second Revolution
The Alliance for Regenerative Medicine reported in its January 2024 meeting that, up to 17 regulatory approval...Read more
India | 21 May 2024 | News
Glenmark to commercialise BeiGene's oncology medicines Tislelizumab and Zanubrutinib in India
Glenmark Specialty S.A., a subsidiary of Indian firm Glenmark Pharmaceuticals has announced an exclusive marke...Read more
Singapore | 20 May 2024 | News
AstraZeneca to invest $1.5 B for building ADCs manufacturing facility in Singapore
British multinational pharmaceutical company AstraZeneca intends to build a $1.5 billion manufacturi...Read more
Middle East countries | 18 May 2024 | News
Abu Dhabi govt signs MoU with Roche Pharma to elevate research, clinical trials and real-world data
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has s...Read more
Japan | 21 May 2024 | News
Astellas partners with Yaskawa to create innovative cell therapy ecosystem in Japan
Astellas Pharma Inc. has signed a Memorandum of Understanding (MoU) with Yaskawa Electric Corporation to begin...Read more
China | 20 May 2024 | News
China's Duoning Biotech to commercialise single-cell sorting system for antibody discovery
Duoning Biotechnology Group, a leading one-stop bioprocess provider in China, has announced a strategic p...Read more
Singapore | 13 May 2024 | News
Singapore suggests repurposing of existing cancer drugs to treat aggressive brain cancer
Glioblastoma is an often fatal form of brain cancer, with only five per cent of patients surviving beyond five...Read more
China | 21 May 2024 | News
Hong Kong-based startup Eieling Technology implements large-scale liver disease screening programme
According to the '2024 Global Hepatitis Report' by the World Health Organization, the number of lives lost due...Read more
Europe | 13 May 2024 | News
Siemens invests £250 M in UK’s first major production site for new MRI cooling technology
Siemens Healthineers has announced a new facility in North Oxfordshire, UK that will design and manufacture su...Read more
China | 08 May 2024 | News
Medtronic receives approval for first Symplicity Spyral Renal Denervation System in China
Medtronic has received approval from the National Medical Products Administration (NMPA) in China for its Symp...Read more
Korea | 21 May 2024 | News
Radyus Research and Dt&CRO to pave way for South Korean biotech companies into US
Radyus Research, a global drug development organisation from US, has announced a pivotal strategic partnership...Read more
Korea | 08 May 2024 | News
Avance Clinical expands further into APAC with new clinical operations in South Korea
Avance Clinical has announced the opening of new clinical operations in Seoul, South Korea. Ava...Read more
Australia | 07 May 2024 | News
IDT Australia has been awarded a Victoria State Government grant to part fund the establishment of Aus...Read more
What’s APAC’s Recipe of Success in CLINICAL TRIALS MARKET?
Asia-Pacific (APAC) is emerging as one of the most promising and resilient markets for clinical trials. According to a report by Clinical Trials Arena, between 2017 and 2022, the region posted growth in clinical trials of around 10 per cent, outstripping growth in other major regions including the US, Europe and the rest of the world (RoW). Asia’s growth far exceeded the overall average figure of 5.3 per cent per year. As of 2023, the number of trials reached 14,346 in APAC. Let's delve into the thriving clinical research landscape in the region and explore the trends driving its growth.